Goldman Sachs Maintains Neutral on Bruker, Lowers Price Target to $45

Benzinga · 4d ago
Goldman Sachs analyst Matthew Sykes maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the price target from $50 to $45.